Open AccessThe Evaluation of Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
Author(s) -
Sinan Mersin,
Ayfer Gedük,
Özgür Mehtap,
Pınar Tarkun,
Serkan Ünal,
Merve Gökçen Polat,
Kemal Aygün,
Emel Merve Yenihayat,
Hayrunnisa Albayrak,
Abdullah Hacıhanefioğlu
Publication year - 2021
Publication title -
turkish journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.351
H-Index - 16
ISSN - 1300-7777
DOI - 10.4274/tjh.galenos.2021.2020.0555
Subject(s) - bortezomib , medicine , multiple myeloma , cytopenia , retrospective cohort study , oncology , surgery , bone marrow
Constantly increasing health expenditures lead to the use of generic molecules and generic versions of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects, and reliability of generic bortezomib in newly diagnosed multiple myeloma (MM) patients.